Voice Prosthesis for Voice Rehabilitation Following Total Laryngectomy
Customize your policy alerts
Sign up for Aetna Policy 0560 alerts
Get alerted when Policy 0560 changes without checking for updates manually.
Monitor payer policy activity
This policy governs medical necessity, replacement, and coding for indwelling and non-indwelling tracheo-esophageal (TE) voice prostheses and handheld artificial larynx devices for voice rehabilitation after total laryngectomy for Aetna members.
No material clinical or coverage changes in this revision.
Coverage and Medical Necessity Criteria
Medical Necessity Criteria
Covered when ALL of the following are met
See Appendix for selection criteria
Replacement is usually carried out as an outpatient procedure
See Appendix for selection criteria
Experimental / Investigational
Not covered / experimental
These items are listed as experimental/investigational in the policy
Selection criteria (indwelling or non-indwelling TE voice prosthesis)
Covered when ALL of the following are met
These two criteria are the Appendix selection criteria for indwelling or non-indwelling TE voice prosthesis
The policy lists Pneumatic Bionic Voice Prostheses and the use of a TE voice prosthesis insufflator as experimental and investigational and therefore excluded from coverage because their clinical value has not been established.
Prophylactic replacement of a voice prosthesis is not considered feasible or appropriate. A retrospective study found marked inter- and intra-patient variability in device lifetime; prophylactic replacement to prevent 70% of leakages would require a median of 9.4 VPs per year (replacement every ~38 days), and simulation showed that preventing 70% of leakages is generally impossible. The authors concluded prophylactic replacement is not feasible due to the high coefficient of variation in device lifetime.
Patients considered for a TE voice prosthesis must be able to manage daily device care and have sufficient respiratory function. Specifically, patients need adequate manual dexterity to clean the prosthesis 2–3 times daily and adequate pulmonary function to force air from the trachea through the prosthesis into the esophagus. Individuals with severe upper-extremity impairment (for example, severe rheumatoid arthritis, amputations, or deformities) or those with severe pulmonary disease and/or repeated pneumonitis are poor candidates for TE voice prostheses under accepted guidelines.
Billing and Coding
| 31611 | Construction of tracheoesophageal fistula and subsequent insertion of an alaryngeal speech prosthesis (e.g., voice button, Blom-Singer prosthesis) |
| 31360-31365 | Laryngectomy, total |
| L8500 | Artificial larynx, any type |
| L8501 | Tracheostomy speaking valve |
| L8505 | Artificial larynx replacement battery/accessory, any type |
| L8507 | Tracheo-esophageal voice prosthesis, patient inserted, any type, each [e.g., the Provox NiD] |
| L8509 | Tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type |
| L8511 | Insert for indwelling tracheoesophageal prosthesis, with or without valve, replacement only, each |
| L8512 | Gelatin capsules or equivalent, for use with tracheoesophageal voice prosthesis, replacement only, per 10 |
| L8513 | Cleaning device used with tracheoesophageal voice prosthesis, pipet, brush, or equal, replacement only, each |
| L8514 | Tracheoesophageal puncture dilator, replacement only, each |
| L8515 | Gelatin capsule, application device for use with tracheoesophageal voice prosthesis, each |
| Pneumatic Bionic Voice Prostheses | No specific code |
| Tracheoesophageal voice prosthesis insufflator | No specific code |
| C32.0-C32.9 | Malignant neoplasm of larynx |
| D02.0 | Carcinoma in situ of larynx |
| D14.1 | Benign neoplasm of larynx |
| Z85.21 | Personal history of malignant neoplasm of larynx |
| Z90.02 | Acquired absence of larynx |
Provider Requirements and Operational Guidance
Codes covered only if selection criteria met; prior auth as required
Certain CPT, HCPCS and ICD-10 codes listed in this policy are covered only when the policy’s selection criteria are met; obtain prior authorization as required by the payer for procedures and prosthesis insertion/replacement using these codes.
PA must document pulmonary function and manual dexterity
Prior authorization documentation should confirm the member meets the policy’s selection criteria by demonstrating adequate pulmonary function to force air through the prosthesis and sufficient manual dexterity to care for the device daily.
- Document pulmonary function sufficient to force air from the trachea through the prosthesis into the esophagus.
- Document manual dexterity to clean and care for the prosthesis 2–3 times daily.
Check policy history and CPB for prior authorization requirements
Refer to the policy history and the Clinical Policy Bulletin (CPB) notes for any payer-specific prior authorization requirements or administrative details related to authorization.
- See Policy History (last review 07/27/2023; next review 06/13/2024) for administrative updates.
- See Clinical Policy Bulletin Notes for additional administrative information.
Recognize indwelling and non-indwelling devices as medically necessary when recommended
The policy recognizes both indwelling and non-indwelling TE voice prostheses as medically necessary when recommended by a laryngologist or speech-language pathologist; device choice may be based on prior device performance and device life evidence.
- Indwelling devices (e.g., Blom-Singer, Provox 2) are covered when recommended.
- Non-indwelling devices (e.g., Provox NiD) are covered when recommended and may be chosen based on durability or patient preference.
No explicit step therapy; use evidence to guide device sequencing
The policy does not impose explicit step therapy or mandatory device sequencing; clinical evidence comparing prosthesis types may inform device selection for failure modes like peri‑prosthetic or endoprosthesis leakage.
- No required trial of one prosthesis type before another is stated in the policy.
- Evidence (e.g., Provox Vega vs XtraSeal, Provox Vega vs ActiValve) may guide selection for recurrent leakage or frequent replacements.
Document removal/replacement technique (e.g., retrograde with Blom‑Singer TEP set)
Providers should follow the documented guidance for removal and replacement techniques (e.g., retrograde removal with the Blom‑Singer TEP set) and include the method used in procedure notes.
- If retrograde technique is used, document use of the Blom‑Singer TEP set and the steps taken to preserve the TEP tract.
Recommendation by laryngologist or SLP and replacement rationale required
A recommendation for initial insertion or replacement must come from a laryngologist or a speech‑language pathologist and the record must document the clinical rationale for replacement (e.g., leakage, device failure) consistent with the selection criteria.
- Treatment plan should state that recommendation was made by a laryngologist or speech‑language pathologist.
- Document the reason for replacement and note device lifespan expectation (typically 3–6 months when clinically indicated).
Document procedure method and confirm eligibility at time of service
Procedure documentation must state the removal/replacement method used and confirm the patient met the selection criteria (adequate pulmonary function and manual dexterity) at the time of service.
- Include the specific technique (e.g., retrograde removal) and devices/tools used.
- Confirm in the record that the member has adequate pulmonary function and manual dexterity per Appendix selection criteria.
Reference policy history for administrative requirements
Refer to the policy history for review dates and administrative changes; providers should consult the policy history for any updates that may affect coverage or preauthorization procedures.
- Last review: 07/27/2023; Effective date: 08/17/2001; Next review: 06/13/2024.
Document manual dexterity and pulmonary function — affects coverage
Patient suitability factors such as manual dexterity and pulmonary function directly affect candidacy and therefore coverage; document these clinical assessments in the medical record.
- Manual dexterity: ability to clean the prosthesis 2–3 times daily affects candidacy.
- Pulmonary function: ability to force air through the prosthesis into the esophagus must be demonstrated.
Not meeting selection criteria risks denial
Failure to meet the policy’s selection criteria (inadequate pulmonary function or insufficient manual dexterity) may result in denial of coverage; ensure documentation supports suitability.
- If records do not demonstrate the two Appendix selection criteria, prior authorization or claim payment may be denied.
CPB notes: guidance only; not an offer of coverage
Clinical Policy Bulletins are intended to assist in administering plan benefits and do not constitute offers of coverage; absence of coverage in a CPB does not change contract language—check member’s plan for definitive coverage terms.
- CPBs provide a general description of benefits and are not a contract or guarantee of coverage.
Clinical Background and Rationale
Tracheo-esophageal (TE) voice prostheses restore speech after total laryngectomy by shunting exhaled air through a one-way valve into the esophagus to produce TE speech. Devices are available as indwelling prostheses, which are secured with flanges and typically replaced by a clinician every few months, and as non-indwelling (patient-inserted) prostheses. Candidacy requires adequate manual dexterity, sufficient pulmonary function, and patient motivation. Leakage of saliva or reflux through or around the prosthesis and increased airflow resistance are the primary indications for inspection and replacement; the general device life is reported as 3–6 months, although durability varies with diet and adherence to daily maintenance.
Definitions and Device Variants
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.